Vyome Inc.

HIND | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.95

+$0.02 (+1.04%)

At close: Sep 22, 2026, 4:00 PM ET

$2.01

+$0.06 (+3.08%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.04%

(1D)

Rating

Updated: Sep 7, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $13.69M

1D Range

1.95 2.08

52W Range

1.75 6.56

Valuation (TTM)

PE -0.06

PB 2.24

EV/EBITDA -0.49

Valuation (NTM)

Forward PE N/A

Forward PEG -0.00

Price Target $3.50

Cash Flow

FCF Yield -38.8%

SBC Adj. FCF Yield -35.6%

SBC Impact -8.1%

Margins

Gross Margin 46.5%

Operating Margin -3250.3%

FCF Margin -4050.0%

Growth (CAGR)

Revenue 3Y | 5Y -76.8% | -60.5%

Dil EPS 3Y | 5Y 135.1% | 88.1%

FCF 3Y | 5Y 23.8% | 39.2%

Returns

ROA -123.2%

ROE -254.6%

ROIC -57.5%

Financial Health

Net Cash

$7.87M

Current Ratio 4.37

Interest Coverage -101.07

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflamm...

Sector Healthcare

Industry Biotechnology

Employees 18

IPO Date Oct 5, 2016

Website www.vyometx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 13, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞